Nadja Schulthess-Lutz

3PUBLICATIONS
5CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 14, 2026
An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes.

Dominik J Schaer, Nadja Schulthess-Lutz, Matthias J Peterhans

|Nov 01, 2025
Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy.

Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia

|Jan 02, 2023
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.

Marc Pfefferlé, Irina L Dubach, Raphael M Buzzi

Pageof 1

Frequent Collaborators

3 joint publications

Florence Vallelian

1 joint publications

Elena Duerst

1 joint publications

Matthias J Peterhans

1 joint publications

Livio Baselgia